Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients. Academic Article uri icon

Overview

publication date

  • September 6, 2021

Identity

PubMed Central ID

  • PMC8418987

Scopus Document Identifier

  • 85118576916

Digital Object Identifier (DOI)

  • 10.1101/2021.05.19.21257469

PubMed ID

  • 34514186

Additional Document Info

volume

  • 6

issue

  • 11